Skip to main content
. 2020 Feb 25;42(2):515–526. doi: 10.1007/s11096-020-00994-6

Fig. 1.

Fig. 1

Frequency of treatment choices considering liver injury and treatment experiences. Elb elbasvir/grisepravir, Sof/Led sofosbuvir/ledipasvir, Gle/Pib glecaprevir/pibrentasvir, Omb/Par/Rit/Das ombitasvir/paritapravir/ritonavir/dasabuvir, R ribavirin, Peg pegylated interferon, Sim simprevir, Led ledipasvir, Vel velpatasvir